PortfoliosLab logoPortfoliosLab logo
COVTY vs. LLY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

COVTY vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Covestro ADR (COVTY) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, COVTY achieves a 0.60% return, which is significantly lower than LLY's 5.64% return.


COVTY

1D
-0.44%
1M
-2.99%
YTD
0.60%
6M
-2.02%
1Y
-1.49%
3Y*
17.68%
5Y*
0.54%
10Y*

LLY

1D
0.55%
1M
14.82%
YTD
5.64%
6M
12.37%
1Y
48.81%
3Y*
37.66%
5Y*
42.48%
10Y*
33.36%
*Multi-year figures are annualized to reflect compound growth (CAGR)

COVTY vs. LLY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
COVTY
Covestro ADR
0.60%15.75%-0.88%50.21%-31.89%3.10%39.29%-5.98%-50.89%54.46%
LLY
Eli Lilly and Company
5.64%40.25%33.30%60.91%34.26%66.08%31.04%16.14%40.45%17.83%

Correlation

The correlation between COVTY and LLY is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.06

Correlation (5Y)
Calculated over the trailing 5-year period

0.04

Correlation (All Time)
Calculated using the full available price history since Dec 15, 2016

0.07

Fundamentals

Market Cap

COVTY:

$12.87B

LLY:

$1.01T

EPS

COVTY:

-$1.69

LLY:

$28.14

PS Ratio

COVTY:

0.99

LLY:

14.06

PB Ratio

COVTY:

1.84

LLY:

32.49

Total Revenue (TTM)

COVTY:

$12.91B

LLY:

$72.25B

Gross Profit (TTM)

COVTY:

$1.71B

LLY:

$59.75B

EBITDA (TTM)

COVTY:

$733.54M

LLY:

$32.97B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

COVTY vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

COVTY
COVTY Risk / Return Rank: 3535
Overall Rank
COVTY Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
COVTY Sortino Ratio Rank: 3333
Sortino Ratio Rank
COVTY Omega Ratio Rank: 3232
Omega Ratio Rank
COVTY Calmar Ratio Rank: 3737
Calmar Ratio Rank
COVTY Martin Ratio Rank: 3535
Martin Ratio Rank

LLY
LLY Risk / Return Rank: 7575
Overall Rank
LLY Sharpe Ratio Rank: 7878
Sharpe Ratio Rank
LLY Sortino Ratio Rank: 7272
Sortino Ratio Rank
LLY Omega Ratio Rank: 7474
Omega Ratio Rank
LLY Calmar Ratio Rank: 7575
Calmar Ratio Rank
LLY Martin Ratio Rank: 7676
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

COVTY vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Covestro ADR (COVTY) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


COVTYLLYDifference
Sharpe ratioReturn per unit of total volatility

-1.35

Sortino ratioReturn per unit of downside risk

-1.78

Omega ratioGain probability vs. loss probability

1.01

1.25

-0.24

Calmar ratioReturn relative to maximum drawdown

-0.15

2.07

-2.22

Martin ratioReturn relative to average drawdown

-0.38

5.16

-5.55

COVTY vs. LLY - Sharpe Ratio Comparison

The current COVTY Sharpe Ratio is -0.06, which is lower than the LLY Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of COVTY and LLY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


COVTYLLYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.06

1.29

-1.35

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.02

1.30

-1.28

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

1.11

Sharpe Ratio (All Time)

Calculated using the full available price history

0.07

0.58

-0.51

Drawdowns

COVTY vs. LLY - Drawdown Comparison

The maximum COVTY drawdown since its inception was -77.54%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for COVTY and LLY.


Loading charts...

Drawdown Indicators


COVTYLLYDifference

Max Drawdown

Largest peak-to-trough decline

-77.54%

-68.24%

-9.30%

Max Drawdown (1Y)

Largest decline over 1 year

-10.23%

-23.64%

+13.41%

Max Drawdown (3Y)

Largest decline over 3 years

-16.19%

-34.48%

+18.29%

Max Drawdown (5Y)

Largest decline over 5 years

-57.37%

-34.48%

-22.89%

Max Drawdown (10Y)

Largest decline over 10 years

-34.48%

Current Drawdown

Current decline from peak

-34.53%

0.00%

-34.53%

Average Drawdown

Average peak-to-trough decline

-42.07%

-19.22%

-22.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.88%

9.49%

-5.61%

Volatility

COVTY vs. LLY - Volatility Comparison

The current volatility for Covestro ADR (COVTY) is 6.57%, while Eli Lilly and Company (LLY) has a volatility of 9.72%. This indicates that COVTY experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


COVTYLLYDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.57%

9.72%

-3.15%

Volatility (6M)

Calculated over the trailing 6-month period

17.73%

27.08%

-9.35%

Volatility (1Y)

Calculated over the trailing 1-year period

23.93%

38.06%

-14.13%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

30.94%

32.83%

-1.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.37%

30.17%

+4.20%

Dividends

COVTY vs. LLY - Dividend Comparison

COVTY has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.57%.


PositionTTM20252024202320222021202020192018201720162015
COVTY
Covestro ADR
0.00%0.00%0.00%0.00%9.64%2.53%2.23%4.26%3.92%2.44%0.00%0.00%
LLY
Eli Lilly and Company
0.57%0.56%0.67%0.78%1.07%1.23%1.75%1.96%1.94%2.46%2.77%2.37%

Financials

COVTY vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Covestro ADR and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00B10.00B15.00B20.00B20222023202420252026
2.89B
19.80B
(COVTY) Total Revenue
(LLY) Total Revenue
Values in USD except per share items

COVTY vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Covestro ADR and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%20222023202420252026
7.3%
79.0%
Portfolio components
COVTY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Covestro ADR reported a gross profit of 210.01M and revenue of 2.89B. Therefore, the gross margin over that period was 7.3%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a gross profit of 15.64B and revenue of 19.80B. Therefore, the gross margin over that period was 79.0%.

COVTY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Covestro ADR reported an operating income of -317.00M and revenue of 2.89B, resulting in an operating margin of -11.0%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported an operating income of 9.19B and revenue of 19.80B, resulting in an operating margin of 46.4%.

COVTY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Covestro ADR reported a net income of -374.46M and revenue of 2.89B, resulting in a net margin of -13.0%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Eli Lilly and Company reported a net income of 7.40B and revenue of 19.80B, resulting in a net margin of 37.4%.


Frequently Asked Questions


COVTY and LLY have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LLY has higher volatility (9.72%) compared to COVTY (6.57%). In terms of maximum drawdown, COVTY dropped -77.54% vs LLY's -68.24%.

LLY currently has the higher Sharpe Ratio (1.29 vs -0.06), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for COVTY and LLY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer